| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.31 | 1e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.23 | 0.0009 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |